to determine whether improved cardiac performance would lower avp levels , 18 chf patients received the experimental agent mdl 17,043 , with improved cardiac index ( 1.9 +/- 0.4 to 3.3 +/- 0.7 1 . min-1 . m-2 , p less than 0.001 ) .
C0018787
cardiac
C0018802
chf